BioClinica grabs a pair of clinical trials software deals; Medidata adds CRO to partnership program;

> BioClinica ($BIOC) has landed a contract with biotech Amarin ($AMRN) to provide its suite of clinical trials software to support clinical data capture and management in a Phase IIIb trial. Release

> On a roll? BioClinica also nabbed a licensing deal for its clinical trial management system (CTMS) software with German pharma group Grünenthal. Announcement

> Bracket, a provider of software for clinical trials within United BioSource, said it has joined the Critical Path Institute's effort to boost the quality of electronic patient-reported outcomes (ePRO) in clinical research. Release

> Technical computing company SGI ($SGI) said Japan's National Institute of Genetics has tapped the company's SGI UV 1000 system for a new supercomputer. Release

> Metabolon, a provider of biochemical profiling technology, has published a chapter in the book "Metabolomics" called "Software Techniques for Enabling High-Throughput Analysis of Metabolomic Datasets." Item

> Prometrika, a CRO, has joined Medidata Solutions' ($MDSO) partnership program to offer its sponsors Medidata's clinical trials software. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.